Change - Announcement of Cessation::Cessation of Dr Melvin Lim Chun Siong as Independent Director

Issuer & Securities

Issuer/ Manager
QUANTUM HEALTHCARE LIMITED
Securities
QUANTUM HEALTHCARE LIMITED - SGXE57350022 - V8Y
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
19-Feb-2026 22:08:29
Status
New
Announcement Sub Title
Cessation of Dr Melvin Lim Chun Siong as Independent Director
Announcement Reference
SG260219OTHRBKCQ
Submitted By (Co./ Ind. Name)
Gan Siong Lin Jimmy
Designation
Chief Executive Officer and Executive Director
Description (Please provide a detailed description of the event in the box below)
Cessation of Dr Melvin Lim Chun Siong as Independent Director.

This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte.Ltd. ("Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Foo Jien Jieng, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg.

Additional Details

Name of person
Dr Melvin Lim Chun Siong
Age
48
Is effective date of cessation known?
Yes
If yes, please provide the date.
19/02/2026
Detailed reason(s) for cessation
Dr Melvin Lim Chun Siong ("Dr Melvin") has resigned from his position as an Independent Director of the Company due to personal reasons and as part of ongoing Board renewal process. He will concurrently relinquish his position as Chairman of the Nominating Committee, member of the Audit Committee and member of the Remuneration Committee. The Board would like to express its heartfelt gratitude towards Dr Melvin for his invaluable contributions to the Company during his tenure of service.

After having interviewed Dr Melvin and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte.Ltd., is satisfied that save as disclosed in this announcement, there are no other material reasons for the resignation of Dr Melvin as an Independent Director of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of appointment to current position
05/11/2024
Job title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director

Chairman of the Nominating Committee

Member of the Audit Committee

Member of the Remuneration Committee
Role and responsibilities
To perform the functions of an Independent Director, Chairman of the Nominating Committee, member of the Audit Committee and Member of the Remuneration Committee.
Does the AC have a minimum of 3 members (taking into account this cessation)?
No
Number of independent directors currently resident in Singapore (taking into account this cessation)
2
Do independent directors make up at least one-third of the board (taking into account this cessation)?
Yes
Number of cessations of appointments specified in Mainboard Rule 704(7) or Catalist Rule 704(6) over the past 12 months
2
Shareholding interest in the listed issuer and its subsidiaries
Yes
Shareholding details
26,909,091 Ordinary Shares
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Other Directorships
Past (for the last 5 years)
Singapore Institute of Technology, Assistant Director
Present
No